Evaluation of osteocalcin and osteopontin among women with osteoporosis in Wasit province, Iraq
Keywords:
osteoporosis, osteocalcin, osteopontinAbstract
Background: Osteoporosis (OP) is one of the most common metabolic diseases, characterized by low bone mass and abnormal bone microarchitecture leading to the development of fractures and subsequent disability. Disruption of bone remodeling by osteoporosis results in an imbalance between bone formation by osteoblasts and resorption by osteoclasts. Aims: This study was aimed to investigate relationship between Osteocalcin and Osteopontin, with estimating their effects on osteoporosis in women and the benefits in diagnosis. Materials and method: In this study, 50women who were referred to DEXA unit in Al-Karama Teaching Hospital to diagnosed with Osteoporosis. They were compared with 40 healthy individuals who did not have any clinical symptoms. Blood samples were used after separating them by a centrifuge for the purpose of examining levels of vital indicators were detected by Enzyme linked immunosorbent assay (ELISA). Results: The results of the current study showed a decrease in the level of Osteocalcin, increasing in the levels of Osteopontin, with significant differences between the study groups at P≤0.0001 compared to the control group. osteoporosis
Downloads
References
Allah, A. M. A., El Tarhouny, S. A., Khodeer, S. A., & Shehab-Eldin, W. A. (2017). The value of osteopontin and matrix metalloproteinase-3 in the assessment of bone mineral density in postmenopausal women. Menoufia Medical Journal, 30(4), 1065.
Bolarin, D. M., Ekpe, E. L., Saidu, K., andEyam, E. S. (2016). A glance at biomarkers of bone metabolism. Pakistan Journal of Nutrition, 15(5), 499.
Chan, G. M., Riandini, T., Ng, S. H. X., Goh, S. Y., Tan, C. S., Tai, E. S., ... & Venkataraman, K. (2018). Role of fat and bone biomarkers in the relationship between ethnicity and bone mineral density in older men. Calcified tissue international, 102(1), 64-72.
Chapurlat, R. D. (2015). Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women. Therapeutic advances in musculoskeletal disease, 7(3), 103-109.
Cho, E. H., Cho, K. H., Lee, H. A., & Kim, S. W. (2013). High serum osteopontin levels are associated with low bone mineral density in postmenopausal women. Journal of Korean Medical Science, 28(10), 1496-1499.
Clemente, N., Raineri, D., Cappellano, G., Boggio, E., Favero, F., Soluri, M. F., ... & Chiocchetti, A. (2016). Osteopontin bridging innate and adaptive immunity in autoimmune diseases. Journal of immunology research, 2016.
Ge, D. W., Wang, W. W., Chen, H. T., Yang, L., and Cao, X. J. (2017). Functions of microRNAs in osteoporosis. Eur Rev Med PharmacolSci, 21(21), 4784-9.
Hamdi, Rana A. "Evaluation of Serum Osteocalcin level in Iraqi Postmenopausal women with primary osteoporosis." Journal of the Faculty of Medicine Baghdad 55.2 (2013).
Hsu, T. L., Tantoh, D. M., Chou, Y. H., Hsu, S. Y., Ho, C. C., Lung, C. C., ... andLiaw, Y. P. (2020). Association between osteoporosis and menopause in relation to SOX6 rs297325 variant in Taiwanese women. Menopause (New York, NY), 27(8), 887.
Jagtap, V. R., & Ganu, J. V. (2011). Serum osteocalcin: A specific marker for bone formation in postmenopausal osteoporosis. Bone, 2(5).
Kadam, N. S., Chiplonkar, S. A., Khadilkar, A. V., andKhadilkar, V. V. (2018). Prevalence of osteoporosis in apparently healthy adults above 40 years of age in Pune City, India. Indian journal of endocrinology and metabolism, 22(1), 67.
Kuo, T. R., & Chen, C. H. (2017). Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomarker research, 5(1), 1-9.
Lorentzon, M., Branco, J., Brandi, M. L., Bruyère, O., Chapurlat, R., Cooper, C., ... & Cavalier, E. (2019). Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis. Advances in therapy, 36(10), 2811-2824.
Mera, P., Laue, K., Ferron, M., Confavreux, C., Wei, J., Galán-Díez, M., ... & Karsenty, G. (2016). Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell metabolism, 23(6), 1078-1092.
Paldánius, P. M. (2017). The role of osteocalcin in human bone metabolism and glucose homeostasis.
Patti, A., Gennari, L., Merlotti, D., Dotta, F., & Nuti, R. (2013). Endocrine actions of osteocalcin. International journal of endocrinology, 2013.
Shetty, S., Kapoor, N., Bondu, J. D., Thomas, N., & Paul, T. V. (2016). Bone turnover markers: Emerging tool in the management of osteoporosis. Indian journal of endocrinology and metabolism, 20(6), 846.
Si, J., Wang, C., Zhang, D., Wang, B., Hou, W., and Zhou, Y. (2020). Osteopontin in bone metabolism and bone diseases. Medical science monitor: international medical journal of experimental and clinical research, 26, e919159-1.
Singh, A., Gill, G., Kaur, H., Amhmed, M., & Jakhu, H. (2018). Role of osteopontin in bone remodeling and orthodontic tooth movement: a review. Progress in orthodontics, 19(1), 1-8.
Singh, S., Kumar, D., & Lal, A. K. (2015). Serum osteocalcin as a diagnostic biomarker for primary osteoporosis in women. Journal of clinical and diagnostic research: JCDR, 9(8), RC04.
Skinner, J. E. (2020). Vitamin K and equine osteocalcin: an enigma explored (Doctoral dissertation, University of Queensland).
Sofija, G., & Ivan, T. (2018). Quality of life in children with disabilities placed in foster families. International Journal of Health & Medical Sciences, 1(1), 18-27. https://doi.org/10.31295/ijhms.v1n1.35
Sözen, T., Özışık, L., andBaşaran, N. Ç. (2017). An overview and management of osteoporosis. European journal of rheumatology, 4(1), 46.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
Uede, T. (2011). Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathology international, 61(5), 265-280.
Wei, Q. S., Huang, L., Tan, X., Chen, Z. Q., Chen, S. M., & Deng, W. M. (2016). Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women. Scandinavian Journal of Clinical and Laboratory Investigation, 76(1), 33-39.
Wu, Q. Y., Li, X., Miao, Z. N., Ye, J. X., Wang, B., Zhang, F., ... and Yuan, F. L. (2018). Long non-coding RNAs: a new regulatory code for osteoporosis. Frontiers in Endocrinology, 587.
Zoch, M. L., Clemens, T. L., & Riddle, R. C. (2016). New insights into the biology of osteocalcin. Bone, 82, 42-49.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
